Dinoprostone
Delivery
Centre Hospitalier Departemental VendeeSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Delivery cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cefazolin Michael Stitely | Phase 4 | BBB |
Misoprostol University of Texas at Austin | Phase 4 | BBB |
Misoprostol University of Texas at Austin | Phase 4 | BB |
PROSTAGLANDIN E1 Hillel Yaffe Medical Center | Phase 2/3 | B |
Acetylsalicylic Acid Instituto Nacional de Investigacao em Saude, Angola | Phase 1/2 | CC |
Oxcarbamezapine University of Pittsburgh | D | |
LAMOTRIGINE University of Pittsburgh | D |
Same molecule, other indications
Dinoprostone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →